✦ LIBER ✦

Lack of minocycline efficiency in genetic models of Huntington’s disease

✍ Scribed by Stéphane Mievis; Marc Levivier; David Communi; Gilbert Vassart; Jacques Brotchi; Catherine Ledent; David Blum

Book ID: 111642319
Publisher: Humana Press Inc
Year: 2007
Tongue: English
Weight: 228 KB
Volume: 9
Category: Article
ISSN: 1535-1084
DOI: 10.1385/nmm:9:1:47

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Minocycline in phenotypic models of Hunt

Minocycline in phenotypic models of Huntington's disease

✍ Kadiombo Bantubungi; Carine Jacquard; Anita Greco; Annita Pintor; Abdelwahed Cht 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 697 KB

Deleterious effects of minocycline in an

Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease

✍ Elsa Diguet; Pierre-Olivier Fernagut; Xing Wei; Yansheng Du; Richard Rouland; Ch 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB

Minocycline is protective in a mouse mod

Minocycline is protective in a mouse model of Huntington's disease

✍ Steven Hersch; Klaus Fink; Jean Paul Vonsattel; Robert M. Friedlander 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Minocycline beneficial in Huntington's d

Minocycline beneficial in Huntington's disease

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 155 KB

Minocycline: potential in Huntington's d

Minocycline: potential in Huntington's disease?

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 154 KB

A futility study of minocycline in Hunti

A futility study of minocycline in Huntington's disease

✍ Dr. Merit Cudkowicz; The Huntington Study Group DOMINO Investigators 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

## Abstract This study assessed the futility of proceeding with a Phase 3 clinical trial of minocycline as a disease‐modifying treatment for Huntington's disease (HD). One hundred fourteen research participants with HD were randomized, 87 to minocycline (200 mg/d) and 27 to placebo. The change in T